A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
BACKGROUND: Therapeutic strategies targeting immune Jewelry Holders checkpoint proteins have led to significant responses in patients with various tumor types.The success of these studies has led to the development of various antibodies/inhibitors for the different checkpoint proteins involved in immune evasion of the tumor.Adenosine present in hig